Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC NSC139021-200MG
SDP

Catalog No. 5000568854
Encompass_Preferred

NSC139021 (CAS No 1147-56-4) is a compound within the category of biomedical research chemicals primarily studied for its potential effects on cellular pathways involved in cancer treatment Originating from targeted synthesis efforts NSC139021 is known to interact with specific signaling pathways potentially inhibiting the proliferation of cancer cells Its mechanism often involves disruption of cellular replication processes leading to cell cycle arrest or apoptosis The compound exhibits activity in the nanomolar to low micromolar range indicating its potency in laboratory settings It is frequently used in in vitro studies involving various cancer cell lines and in vivo animal models to assess its efficacy and therapeutic potential NSC139021 is also employed in drug screening programs aimed at discovering novel anticancer agents Experimental concentrations typically depend on the specific research design allowing flexibility in use across different experimental setups

Catalog No. 50-005-68854 Supplier Apexbio Technology LLC Supplier No. C6598200
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

NSC139021 (CAS No 1147-56-4) is a compound within the category of biomedical research chemicals primarily studied for its potential effects on cellular pathways involved in cancer treatment Originating from targeted synthesis efforts NSC139021 is known to interact with specific signaling pathways potentially inhibiting the proliferation of cancer cells Its mechanism often involves disruption of cellular replication processes leading to cell cycle arrest or apoptosis The compound exhibits activity in the nanomolar to low micromolar range indicating its potency in laboratory settings It is frequently used in in vitro studies involving various cancer cell lines and in vivo animal models to assess its efficacy and therapeutic potential NSC139021 is also employed in drug screening programs aimed at discovering novel anticancer agents Experimental concentrations typically depend on the specific research design allowing flexibility in use across different experimental setups

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.